Clinical Trials Browser

Suspended × INDUSTRY × Gastrointestinal × Clear all

NCT05435014 2026-04-14

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

Phase 1/2 Suspended

Gastrointestinal

Carcinoma, Hepatocellular

NCT05033522 2025-10-23

ALIVE

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05494697 2025-10-14

Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC

Phase 2 Suspended

Gastrointestinal

Pancreatic Neoplasms

NCT03417921 2025-10-01

Pancreatic

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

NCT04693546 2025-09-26

PREVENT

12,000 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05958199 2025-06-27

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Phase 1 Suspended

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT05603572 2025-06-05

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Phase 1/2 Suspended

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

NCT05191667 2025-02-13

AN0025 and Chemoradiotherapy Combination in Esophageal Cancer

Phase 1 Suspended

Gastrointestinal

Esophageal Neoplasms

NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

Phase 1 Suspended

BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT04650451 2023-04-20

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

Phase 1 Suspended

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT03970382 2022-08-18

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Phase 1 Suspended

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT03253575 2019-04-08

ANCERS-2

BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT02026362 2017-10-18

HCC DC CTL

Phase 1/2 Suspended

Gastrointestinal

Carcinoma, Hepatocellular

NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Phase 1 Suspended

BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00637364 2009-01-13

HIFU Pancreas

Phase 1/2 Suspended

Gastrointestinal

Pain, Pancreatic Neoplasms

NCT00443573 2008-05-07

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

Phase 1/2 Suspended

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms

NCT00536770 2007-11-06

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Phase 2 Suspended

Gastrointestinal

Pancreatic Neoplasms

NCT00048529 2005-06-24

Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus

Phase 2 Suspended

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms